Publication
Title
Osteonecrosis of the jaw (ONJ) might explain the increased oral surgery risk in cancer patients treated with bisphosphonates
Author
Abstract
The medical claims data of approximately 20 million patients was analyzed from the beginning of 2001 through December 2004. Patients with breast, prostate, or lung cancer or multiple myeloma were eligible for inclusion. Claims associated with surgery to the maxilla or mandible were included if they were registered after treatment with a bisphosphonate (BP) was initiated (Figure 1). The median age of intravenous (IV) users (64 years) was higher than patients on oral BPs (59 years), but compared with never-users no statistically significant difference was found. Data on gender distribution, disease severity, or indication for BP use was not provided by the authors.
Language
English
Source (journal)
˜The œjournal of evidence-based dental practice. - St. Louis, MO, 2001, currens
Journal of evidence-based dental practice. - Saint Louis, Ill.
Publication
St. Louis, MO : Mosby, Inc , 2007
ISSN
1532-3382
Volume/pages
7 :3 (2007) , p. 132-135
Number
1532-3382
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Record
Identification
Creation 19.03.2018
Last edited 15.07.2021
To cite this reference